Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Diabetes

Free Subscription 22.02.2021 1 Acta Ophthalmol 4 Am J Kidney Dis 1 Am J Manag Care 1 Biochem Biophys Res Commun 2 BMC Ophthalmol 1 BMC Pediatr 3 Diabet Med 2 Diabetes 6 Diabetes Care 8 Diabetes Obes Metab 4 Diabetologia 2 Eur J Endocrinol 1 Invest Ophthalmol Vis Sci 3 J Am Coll Cardiol 1 J Am Coll Nutr 8 J Clin Endocrinol Metab 1 J Clin Invest 2 J Diabetes Complications 1 J Hypertens 1 J Immunol 1 JAMA 1 Metabolism 1 Obstet Gynecol 10 Pediatr Diabetes 5 PLoS One 2 Retina 2 Stroke

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Ophthalmol

1. MANKOC RAMUS S, Pungersek G, Petrovic MG, Petrovic D, et al
   The GG genotype of erythropoietin rs1617640 polymorphism affects the risk of proliferative diabetic retinopathy in Slovenian subjects with type 2 diabetes mellitus: enemy or ally?
   Acta Ophthalmol. 2021 Feb 17. doi: 10.1111/aos.14813.
   PubMed         Abstract available
   
   

   
   Am J Kidney Dis

2. JOSHI S, McMacken M, Kalantar-Zadeh K
   Plant-Based Diets for Kidney Disease: A Guide for Clinicians.
   Am J Kidney Dis. 2021;77:287-296.
   PubMed         Abstract available
   
   
3. SOHANEY R, Yin H, Shahinian V, Saran R, et al
   Trends in the Incidence of Acute Kidney Injury in a National Cohort of US Veterans.
   Am J Kidney Dis. 2021;77:300-302.
   PubMed        
   
   
4. 
   Erratum Regarding "SGLT2 Inhibition for the Prevention and Treatment of Diabetic Kidney Disease: A Review" (Am J Kidney Dis. 2018;72[2]:267-277).
   Am J Kidney Dis. 2021 Feb 10. pii: S0272-6386(21)00026.
   PubMed        
   
   
5. CERVANTES CE, Menez S, Monroy Trujillo JM, Hanouneh M, et al
   Clinical Approach to a Patient With an Acid-Base Disturbance.
   Am J Kidney Dis. 2021;77:A9-A11.
   PubMed        
   
   

   
   Am J Manag Care

6. AKIROV A, Shochat T, Shimon I
   Solid-organ transplant recipients with hyperglycemia on admission face worse outcomes.
   Am J Manag Care. 2020;26:163-168.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

7. CAO Y, Han X, Wang Z, Liu Y, et al
   TLR4 knockout ameliorates streptozotocin-induced osteoporosis in a mouse model of diabetes.
   Biochem Biophys Res Commun. 2021;546:185-191.
   PubMed         Abstract available
   
   

   
   BMC Ophthalmol

8. GHASSEMI F, Fadakar K, Berijani S, Babeli A, et al
   Quantitative assessment of vascular density in diabetic retinopathy subtypes with optical coherence tomography angiography.
   BMC Ophthalmol. 2021;21:82.
   PubMed         Abstract available
   
   
9. LIU X, Jiang Z, Zhang G, Ng TK, et al
   Association of UCP1 and UCP2 variants with diabetic retinopathy susceptibility in type-2 diabetes mellitus patients: a meta-analysis.
   BMC Ophthalmol. 2021;21:81.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

10. SABER AM, Mohamed MA, Sadek AA, Mahmoud RA, et al
    Role of umbilical cord C-peptide levels in early prediction of hypoglycemia in infants of diabetic mothers.
    BMC Pediatr. 2021;21:85.
    PubMed         Abstract available
    
    

    
    Diabet Med

11. BOAZ M, Azoulay O, Kaufman-Shriqui V, Weinstein T, et al
    Status of Nutrition in Hemodialysis Patients Survey (SNIPS): Malnutrition risk by diabetes status.
    Diabet Med. 2021 Feb 14:e14543. doi: 10.1111/dme.14543.
    PubMed         Abstract available
    
    
12. MEBRAHTU G, Maniam J, James S, Ogle GD, et al
    High incidence of type 1 diabetes in adolescents and young adults in Eritrea.
    Diabet Med. 2021 Feb 15:e14544. doi: 10.1111/dme.14544.
    PubMed         Abstract available
    
    
13. MILLER RG, Orchard TJ, Onengut-Gumuscu S, Chen WM, et al
    Heterogeneous Long-Term Trajectories of Glycaemic Control in Type 1 Diabetes.
    Diabet Med. 2021 Feb 19:e14545. doi: 10.1111/dme.14545.
    PubMed         Abstract available
    
    

    
    Diabetes

14. CAO P, Song Y, Zhuang Z, Ran J, et al
    Obesity and COVID-19 in Adult Patients With Diabetes.
    Diabetes. 2021 Feb 17. pii: db20-0671. doi: 10.2337/db20-0671.
    PubMed         Abstract available
    
    
15. ZENG M, Wen J, Ma Z, Xiao L, et al
    FOXO1-mediated Downregulation of RAB27B Leads to Decreased Exosome Secretion in Diabetic Kidneys.
    Diabetes. 2021 Feb 17. pii: db20-1108. doi: 10.2337/db20-1108.
    PubMed         Abstract available
    
    

    
    Diabetes Care

16. QIAN J, Walkup MP, Chen SH, Brubaker PH, et al
    Association of Objectively Measured Timing of Physical Activity Bouts With Cardiovascular Health in Type 2 Diabetes.
    Diabetes Care. 2021 Feb 17. pii: dc20-2178. doi: 10.2337/dc20-2178.
    PubMed         Abstract available
    
    
17. PERKOVIC V, Toto R, Cooper ME, Mann JFE, et al
    Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial.
    Diabetes Care. 2020;43:1803-1812.
    PubMed         Abstract available
    
    
18. MORITA Y, Nogami M, Sakaguchi K, Okada Y, et al
    Enhanced Release of Glucose Into the Intraluminal Space of the Intestine Associated With Metformin Treatment as Revealed by [(18)F]Fluorodeoxyglucose PET-MRI.
    Diabetes Care. 2020;43:1796-1802.
    PubMed         Abstract available
    
    
19. AGIRREZABAL I, Sanchez-Iriso E, Mandar K, Cabases JM, et al
    Real-World Budget Impact of the Adoption of Insulin Glargine Biosimilars in Primary Care in England (2015-2018).
    Diabetes Care. 2020;43:1767-1773.
    PubMed         Abstract available
    
    
20. COLLYNS OJ, Meier RA, Betts ZL, Chan DSH, et al
    Improved Glycemic Outcomes With Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: Results From a Randomized Crossover Trial Comparing Automated Insulin Delivery With Predictive Low Glucose Suspend in People With Type 1 Diabetes.
    Diabetes Care. 2021 Feb 12. pii: dc20-2250. doi: 10.2337/dc20-2250.
    PubMed         Abstract available
    
    
21. LEMOS JRN, Baidal DA, Ricordi C, Fuenmayor V, et al
    Survival After Islet Transplantation in Subjects With Type 1 Diabetes: Twenty-Year Follow-Up.
    Diabetes Care. 2021 Feb 12. pii: dc20-2458. doi: 10.2337/dc20-2458.
    PubMed        
    
    

    
    Diabetes Obes Metab

22. TIMMONS JG, Greenlaw N, Boyle JG, Chaturvedi N, et al
    Metformin and carotid intima media thickness in never smokers with type 1 diabetes: the REMOVAL trial.
    Diabetes Obes Metab. 2021 Feb 16. doi: 10.1111/dom.14350.
    PubMed        
    
    
23. PASQUEL FJ, Urrutia MA, Cardona S, Zamudio Coronado KW, et al
    Liraglutide Hospital Discharge Trial: A Randomized Controlled Trial Comparing the Safety and Efficacy of Liraglutide versus Glargine Insulin for the Management of Patients with Type 2 Diabetes After Hospital Discharge.
    Diabetes Obes Metab. 2021 Feb 16. doi: 10.1111/dom.14347.
    PubMed         Abstract available
    
    
24. TAKEUCHI Y, Kumamaru H, Hagiwara Y, Matsui H, et al
    Sodium-glucose cotransporter-2 inhibitors and the risk of urinary tract infection among diabetic patients in Japan: Target trial emulation using a nationwide administrative claims database.
    Diabetes Obes Metab. 2021 Feb 19. doi: 10.1111/dom.14353.
    PubMed         Abstract available
    
    
25. BAVIERA M, Genovese S, Lepore V, Colacioppo P, et al
    Lower risk of death and cardiovascular events in patients with diabetes initiating GLP-1 receptor agonists or SGLT-2 inhibitors: a real-world study on two Italian cohorts.
    Diabetes Obes Metab. 2021 Feb 19. doi: 10.1111/dom.14361.
    PubMed         Abstract available
    
    
26. BOUGHTON CK, Hartnell S, Thabit H, Poettler T, et al
    Hybrid closed-loop glucose control with faster insulin aspart (Fiasp) compared with standard insulin aspart in adults with type 1 diabetes: a double-blind, multicentre, multinational, randomised, crossover study.
    Diabetes Obes Metab. 2021 Feb 19. doi: 10.1111/dom.14355.
    PubMed         Abstract available
    
    
27. LAM CSP, Karasik A, Melzer-Cohen C, Cavender Md MA, et al
    Association of SGLT2 inhibitors with outcomes in Type 2 diabetes with reduced and preserved left ventricular ejection fraction - Analysis from the CVD-REAL 2 Study.
    Diabetes Obes Metab. 2021 Feb 19. doi: 10.1111/dom.14356.
    PubMed         Abstract available
    
    
28. JUN M, Harris K, Heerspink H, Badve SV, et al
    Variability in eGFR and the risk of major clinical outcomes in diabetes: post-hoc analysis from the ADVANCE trial.
    Diabetes Obes Metab. 2021 Feb 19. doi: 10.1111/dom.14351.
    PubMed         Abstract available
    
    
29. MCCRIMMON RJ, Al Sifri S, Emral R, Mohan V, et al
    Advancing therapy with iGlarLixi versus Premix 70/30 in basal insulin-treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomised controlled trial.
    Diabetes Obes Metab. 2021 Feb 19. doi: 10.1111/dom.14354.
    PubMed         Abstract available
    
    

    
    Diabetologia

30. WARGNY M, Potier L, Gourdy P, Pichelin M, et al
    Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study.
    Diabetologia. 2021 Feb 17. pii: 10.1007/s00125-020-05351.
    PubMed         Abstract available
    
    
31. VON SCHOLTEN BJ, Kreiner FF, Gough SCL, von Herrath M, et al
    Current and future therapies for type 1 diabetes.
    Diabetologia. 2021 Feb 17. pii: 10.1007/s00125-021-05398.
    PubMed         Abstract available
    
    
32. MBANYA JC, Aschner P, Gagliardino JJ, Ilkova H, et al
    Screening, prevalence, treatment and control of kidney disease in patients with type 1 and type 2 diabetes in low-to-middle-income countries (2005-2017): the International Diabetes Management Practices Study (IDMPS).
    Diabetologia. 2021 Feb 16. pii: 10.1007/s00125-021-05406.
    PubMed         Abstract available
    
    
33. MCGOVERN AP, Thomas NJ, Vollmer SJ, Hattersley AT, et al
    The disproportionate excess mortality risk of COVID-19 in younger people with diabetes warrants vaccination prioritisation.
    Diabetologia. 2021 Feb 16. pii: 10.1007/s00125-021-05404.
    PubMed        
    
    

    
    Eur J Endocrinol

34. JULIAN MT, Pera G, Soldevila B, Caballeria L, et al
    Atherogenic dyslipidemia, but not hyperglycemia, is an independent factor associated with liver fibrosis in subjects with type 2 diabetes and NAFLD: A population -based study.
    Eur J Endocrinol. 2021 Feb 1. pii: EJE-20-1240.R1. doi: 10.1530/EJE-20-1240.
    PubMed         Abstract available
    
    
35. BONFANTI R, Iafusco D, Rabbone I, Diedenhofen G, et al
    Differences between Transient Neonatal Diabetes Mellitus Subtypes can Guide Diagnosis and Therapy.
    Eur J Endocrinol. 2021 Feb 1. pii: EJE-20-1030.R1. doi: 10.1530/EJE-20-1030.
    PubMed         Abstract available
    
    

    
    Invest Ophthalmol Vis Sci

36. ZHOU W, Yang J, Wang Q, Wang Y, et al
    Systemic Stressors and Retinal Microvascular Alterations in People Without Diabetes: The Kailuan Eye Study.
    Invest Ophthalmol Vis Sci. 2021;62:20.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

37. ZEITLER EP, Piccini JP
    Pre-Diabetes and Stroke in Patients With Atrial Fibrillation: When Risk Begets Risk.
    J Am Coll Cardiol. 2021;77:885-887.
    PubMed        
    
    
38. KEZERLE L, Tsadok MA, Akriv A, Senderey AB, et al
    Pre-Diabetes Increases Stroke Risk in Patients With Nonvalvular Atrial Fibrillation.
    J Am Coll Cardiol. 2021;77:875-884.
    PubMed         Abstract available
    
    
39. JANUZZI JL JR, Xu J, Li J, Shaw W, et al
    Effects of Canagliflozin on Amino-Terminal Pro-B-Type Natriuretic Peptide: Implications for Cardiovascular Risk Reduction.
    J Am Coll Cardiol. 2020;76:2076-2085.
    PubMed         Abstract available
    
    

    
    J Am Coll Nutr

40. LIRA NETO JCG, Damasceno MMC, Ciol MA, de Freitas RWJF, et al
    Efficacy of Cinnamon as an Adjuvant in Reducing the Glycemic Biomarkers of Type 2 Diabetes Mellitus: A Three-Month, Randomized, Triple-Blind, Placebo-Controlled Clinical Trial.
    J Am Coll Nutr. 2021 Feb 19:1-9. doi: 10.1080/07315724.2021.1878967.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

41. LAURENTI MC, Dalla Man C, Varghese RT, Andrews JC, et al
    Insulin Pulse Characteristics and Insulin Action in Non-Diabetic Humans.
    J Clin Endocrinol Metab. 2021 Feb 19. pii: 6145034. doi: 10.1210.
    PubMed         Abstract available
    
    
42. BLETSA E, Filippas-Dekouan S, Kostara C, Dafopoulos P, et al
    Effect of dapagliflozin on urine metabolome in patients with type 2 diabetes.
    J Clin Endocrinol Metab. 2021 Feb 16. pii: 6139141. doi: 10.1210.
    PubMed         Abstract available
    
    
43. HJORTEBJERG R, Rasmussen LM, Gude MF, Irmukhamedov A, et al
    Local IGF bioactivity associates with high PAPP-A activity in the pericardial cavity of cardiovascular disease patients.
    J Clin Endocrinol Metab. 2020 Sep 1. pii: 5900391. doi: 10.1210.
    PubMed         Abstract available
    
    
44. EBRAHIMI F, Kutz A, Wagner U, Illigens B, et al
    Excess Mortality Among Hospitalized Patients With Hypopituitarism-A Population-Based, Matched-Cohort Study.
    J Clin Endocrinol Metab. 2020;105.
    PubMed         Abstract available
    
    
45. ALI AM, Mari A, Martinez R, Al-Jobori H, et al
    Improved Beta Cell Glucose Sensitivity Plays Predominant Role in the Decrease in HbA1c with Cana and Lira in T2DM.
    J Clin Endocrinol Metab. 2020;105.
    PubMed         Abstract available
    
    
46. MARZUILLO P, Iafusco D, Zanfardino A, Guarino S, et al
    Acute kidney injury and renal tubular damage in children with type 1 diabetes mellitus onset.
    J Clin Endocrinol Metab. 2021 Feb 17. pii: 6141374. doi: 10.1210.
    PubMed         Abstract available
    
    
47. WAGNER R, Jaghutriz BA, Gerst F, Barroso Oquendo M, et al
    Pancreatic Steatosis Associates With Impaired Insulin Secretion in Genetically Predisposed Individuals.
    J Clin Endocrinol Metab. 2020;105.
    PubMed         Abstract available
    
    
48. SUNDELIN E, Jensen JB, Jakobsen S, Gormsen LC, et al
    Metformin Biodistribution: A Key to Mechanisms of Action?
    J Clin Endocrinol Metab. 2020;105.
    PubMed        
    
    

    
    J Clin Invest

49. CHEN A, Feng Y, Lai H, Ju W, et al
    Soluble RARRES1 induces podocyte apoptosis to promote glomerular disease progression.
    J Clin Invest. 2020;130:5523-5535.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

50. SAGARA M, Iijima T, Kase M, Kato K, et al
    Serum levels of soluble dipeptidyl peptidase-4 in type 2 diabetes are associated with severity of liver fibrosis evaluated by transient elastography (FibroScan) and the FAST (FibroScan-AST) score, a novel index of non-alcoholic steatohepatitis with si
    J Diabetes Complications. 2021 Feb 6:107885. doi: 10.1016/j.jdiacomp.2021.107885
    PubMed         Abstract available
    
    
51. KAHN PA, Liu S, McCoy R, Gabbay RA, et al
    Glucagon use by U.S. adults with type 1 and type 2 diabetes.
    J Diabetes Complications. 2021 Feb 6:107882. doi: 10.1016/j.jdiacomp.2021.107882
    PubMed         Abstract available
    
    

    
    J Hypertens

52. VOLPE M, Gallo G
    Systolic blood pressure target less than 120 mmHg: the 'Chariot Allegory' in hypertension?
    J Hypertens. 2020;38:1462-1463.
    PubMed        
    
    

    
    J Immunol

53. BATRA L, Shrestha P, Zhao H, Woodward KB, et al
    Localized Immunomodulation with PD-L1 Results in Sustained Survival and Function of Allogeneic Islets without Chronic Immunosuppression.
    J Immunol. 2020;204:2840-2851.
    PubMed         Abstract available
    
    

    
    JAMA

54. OGUNWOLE SM, Zera CA, Stanford FC
    Obesity Management in Women of Reproductive Age.
    JAMA. 2021;325:433-434.
    PubMed        
    
    

    
    Metabolism

55. KARLSSON HKR, Kasahara A, Ikeda M, Chibalin A, et al
    Quantitative Phosphoproteomic Analysis of IRS1 in Skeletal Muscle from Men with Normal Glucose Tolerance or Type 2 Diabetes: A Case-Control Study.
    Metabolism. 2021 Feb 10:154726. doi: 10.1016/j.metabol.2021.154726.
    PubMed         Abstract available
    
    

    
    Obstet Gynecol

56. GOYAL S, Kortsmit K, Cox S, D'Angelo DV, et al
    Prevalence of Home Births and Associated Risk Profile and Maternal Characteristics, 2016-2018.
    Obstet Gynecol. 2020 Nov 5. doi: 10.1097/AOG.0000000000004129.
    PubMed         Abstract available
    
    

    
    Pediatr Diabetes

57. SANDY JL, Besancon S, Sidibe AT, Minkailou M, et al
    Rapid increases in observed incidence and prevalence of Type 1 diabetes in children and youth in Mali, 2007-2016.
    Pediatr Diabetes. 2021 Feb 15. doi: 10.1111/pedi.13191.
    PubMed         Abstract available
    
    
58. KIM JY, Tfayli H, Bacha F, Lee S, et al
    beta-cell function, incretin response, and insulin sensitivity of glucose and fat metabolism in obese youth: Relationship to OGTT-time-to-glucose-peak.
    Pediatr Diabetes. 2020;21:18-27.
    PubMed         Abstract available
    
    
59. BERGET C, Messer LH, Vigers T, Frohnert BI, et al
    Six months of hybrid closed loop in the real-world: An evaluation of children and young adults using the 670G system.
    Pediatr Diabetes. 2020;21:310-318.
    PubMed         Abstract available
    
    
60. MESSER LH, Berget C, Vigers T, Pyle L, et al
    Real world hybrid closed-loop discontinuation: Predictors and perceptions of youth discontinuing the 670G system in the first 6 months.
    Pediatr Diabetes. 2020;21:319-327.
    PubMed         Abstract available
    
    
61. KAAR JL, Schmiege SJ, Drews K, Higgins J, et al
    Evaluation of the longitudinal change in health behavior profiles across treatment groups in the TODAY clinical trial.
    Pediatr Diabetes. 2020;21:224-232.
    PubMed         Abstract available
    
    
62. ADDALA A, March C, Marks B, Tommerdahl K, et al
    ISPAD Annual Conference 2019 Highlights.
    Pediatr Diabetes. 2020;21:152-157.
    PubMed        
    
    
63. TATSI EB, Kanaka-Gantenbein C, Scorilas A, Chrousos GP, et al
    Next generation sequencing targeted gene panel in Greek MODY patients increases diagnostic accuracy.
    Pediatr Diabetes. 2020;21:28-39.
    PubMed         Abstract available
    
    
64. AMIN B, Yeduri R, Tumin D, Buckman C, et al
    Insurance coverage and health care use among children with diabetes.
    Pediatr Diabetes. 2021 Feb 19. doi: 10.1111/pedi.13192.
    PubMed         Abstract available
    
    
65. BRODAR KE, Davis EM, Lynn C, Starr-Glass L, et al
    Comprehensive Psychosocial Screening in a Pediatric Diabetes Clinic.
    Pediatr Diabetes. 2021 Feb 19. doi: 10.1111/pedi.13193.
    PubMed         Abstract available
    
    
66. PATTON SR, Clements MA, Marker AM, Nelson EL, et al
    Intervention to reduce hypoglycemia fear in parents of young kids using video-based telehealth (REDCHiP).
    Pediatr Diabetes. 2020;21:112-119.
    PubMed         Abstract available
    
    

    
    PLoS One

67. GEBABO TF, Zewdie TH, Shagaro SS, Haile F, et al
    Determinants of peripheral neuropathy among diabetic patients under follow-up in chronic care clinics of public hospitals at Gamo and Gofa zones, southern Ethiopia.
    PLoS One. 2021;16:e0246722.
    PubMed         Abstract available
    
    
68. TUOHY JF, Bloomfield FH, Crowther CA, Harding JE, et al
    Maternal and neonatal glycaemic control after antenatal corticosteroid administration in women with diabetes in pregnancy: A retrospective cohort study.
    PLoS One. 2021;16:e0246175.
    PubMed         Abstract available
    
    
69. HALLAKOU-BOZEC S, Kergoat M, Fouqueray P, Bolze S, et al
    Imeglimin amplifies glucose-stimulated insulin release from diabetic islets via a distinct mechanism of action.
    PLoS One. 2021;16:e0241651.
    PubMed         Abstract available
    
    
70. LI CX, Liang S, Gao L, Liu H, et al
    Cardiovascular outcomes associated with SGLT-2 inhibitors versus other glucose-lowering drugs in patients with type 2 diabetes: A real-world systematic review and meta-analysis.
    PLoS One. 2021;16:e0244689.
    PubMed         Abstract available
    
    
71. GUPTA S, Bansal S
    Correction: Does a rise in BMI cause an increased risk of diabetes?: Evidence from India.
    PLoS One. 2021;16:e0247537.
    PubMed         Abstract available
    
    

    
    Retina

72. LIU Z, Jiang H, Townsend JH, Wang J, et al
    RETINAL TISSUE PERFUSION REDUCTION BEST DISCRIMINATES EARLY STAGE DIABETIC RETINOPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS.
    Retina. 2021;41:546-554.
    PubMed         Abstract available
    
    
73. BORRELLI E, Sacconi R, Parravano M, Costanzo E, et al
    OCTA Assessment of the Diabetic Macula: a Comparison Study among Different Algorithms.
    Retina. 2021 Feb 11. pii: 00006982-900000000-95556.
    PubMed         Abstract available
    
    

    
    Stroke

74. LEVINE DA, Duncan PW, Nguyen-Huynh MN, Ogedegbe OG, et al
    Interventions Targeting Racial/Ethnic Disparities in Stroke Prevention and Treatment.
    Stroke. 2020;51:3425-3432.
    PubMed         Abstract available
    
    
75. SABER H, Khatibi K, Szeder V, Tateshima S, et al
    Reperfusion Therapy Frequency and Outcomes in Mild Ischemic Stroke in the United States.
    Stroke. 2020 Oct 21:STROKEAHA120030898. doi: 10.1161/STROKEAHA.120.030898.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: